Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

by palligoelme@gmail.com | Apr 21, 2026 | Clinical Trials

​ Conditions: Hepato Cellular Carcinoma (HCC) Interventions: Drug: MRG003 Sponsors: Fudan University Recruiting Conditions: Hepato Cellular Carcinoma (HCC) Interventions: Drug: MRG003 Sponsors: Fudan University...

Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction

by palligoelme@gmail.com | Apr 20, 2026 | Clinical Trials

​ Conditions: Lung Transplant Interventions: Drug: Emapalumab; Drug: Placebo Sponsors: University of California, San Francisco Not yet recruiting Conditions: Lung Transplant Interventions: Drug: Emapalumab; Drug: Placebo Sponsors: University of California, San...

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD

by palligoelme@gmail.com | Apr 20, 2026 | Clinical Trials

​ Conditions: Multi Vessel Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: GENOSS® DCB (Paclitaxel-coated PTCA balloon catheter); Device: Second, Third Generation Drug-Eluting Coronary Stent System Sponsors: Genoss Co., Ltd. Not yet...

A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

by palligoelme@gmail.com | Apr 20, 2026 | Clinical Trials

​ Conditions: IBS (Irritable Bowel Syndrome) Interventions: Device: Variable Compression System Sponsors: PGP Health Recruiting Conditions: IBS (Irritable Bowel Syndrome) Interventions: Device: Variable Compression System Sponsors: PGP Health...

Factors Affecting Immediate Anterior Implants. Reterosepective Clinical Study

by palligoelme@gmail.com | Apr 20, 2026 | Clinical Trials

​ Conditions: Pink Esthetic Score; Implant Survival Rate; Immediate Implant Placement Sponsors: International Dental Contiuing Education Not yet recruiting Conditions: Pink Esthetic Score; Implant Survival Rate; Immediate Implant Placement Sponsors: International...

A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

by palligoelme@gmail.com | Apr 20, 2026 | Clinical Trials

​ Conditions: Ankylosing Spondylitis Interventions: Drug: HS_SW01 cells injection Sponsors: Shenzhen Huishan Biotechnology Co., Ltd.; Southern Medical University, China Not yet recruiting Conditions: Ankylosing Spondylitis Interventions: Drug: HS_SW01 cells injection...